Drug-Drug interactions prediction calculations between cardiovascular drugs and antidepressants for discovering the potential co-medication risks.
Predicting Drug-Drug Interactions (DDIs) enables cost reduction and time savings in the drug discovery process, while effectively screening and optimizing drugs. The intensification of societal aging and the increase in life stress have led to a growing number of patients suffering from both heart d...
Saved in:
Main Authors: | Tie Hua Zhou, Tian Yu Jin, Xi Wei Wang, Ling Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0316021 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential QT-prolonging drug-drug interactions in cardiovascular disease patients
by: Milena Kovačević, et al.
Published: (2025-01-01) -
Prevalence and factors associated with potential clinically significant drug-drug interactions in patients with cardiovascular diseases at hospital admission
by: Marović Iva, et al.
Published: (2024-12-01) -
Potential Interaction of Pinocembrin with Drug Transporters and Hepatic Drug-Metabolizing Enzymes
by: Sirima Sangkapat, et al.
Published: (2025-01-01) -
The Nicotinic Acetylcholine Receptor as a Target for Antidepressant Drug Development
by: Noah S. Philip, et al.
Published: (2012-01-01) -
Proteome-Wide Identification and Comparison of Drug Pockets for Discovering New Drug Indications and Side Effects
by: Renxin Zhang, et al.
Published: (2025-01-01)